Refining which patients benefit from consolidation durvalumab for stage III unresectable NSCLC Published 2023-04-17 Download video MP4 360p Download video MP4 720p Recommendations 31:51 Lung Cancer Breakout: Breakthrough treatments for longer life 06:06 Stage III NSCLC: When to Start Durvalumab 03:17 TOPAZ-1: the addition of durvalumab to chemotherpay for the treatment of BTC in the 1st-line setting 09:45 Pain and myeloma 05:44 Differences in Small Cell vs Non-Small Cell Lung Cancer 06:41 The Role of Surgery in NSCLC Following PACIFIC Trial 09:15 Why Am I Always Tired? Avoid These 6 Energy Vampires | Exhausted 03:24 Dr. Jeffrey Weitzel on Synthetic Lethality in BRCA-Associated Cancer 03:58 16+ Years Cancer-Free Thanks to Immunotherapy: Sharon Belvin's Melanoma Story 58:15 Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022) 06:16 How long will the cancer patient survive? Is Chemotherapy mandatory for cancer? - Dr. Sandeep Nayak 23:03 Appendix Cancer Awareness Month 2022 – An interview with Dr. Paul Sugarbaker 03:46 Understanding Immunotherapy for Lung Cancer 03:54 Looking at the PACIFIC Trial 09:33 Hydrus™ vs iStent® Trabecular MicroBypass Which performed better 18:46 Approach to the Exam for Parkinson's Disease 32:12 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC): Front Line Therapy 05:53 Targeted Therapy in Non-Small Cell Lung Cancer 14:35 What kind of Cancer can be treated with Immunotherapy? | Apollo Hospitals 03:00 Disease State Advanced Soft Tissue Sarcoma Similar videos 01:44 Post-hoc subgroup analysis from PACIFIC: durvalumab after CRT in unresectable stage III EGFRm NSCLC 03:25 Impact of radiation dose to immune cells in unresectable or stage III NSCLC in the durvalumab era 02:10 Dr. Langer on the Benefit of Durvalumab in Stage III NSCLC 01:24 Durvalumab: the new standard of care for NSCLC? 04:43 Treating for Stage III NSCLC After Progression on Durvalumab 03:25 PACIFIC 6: durvalumab after sCRT in patients with NSCLC 01:13 Phase II study of Durvalumab for patients with NSCLC 01:04 Dr. Garon on Immunotherapy in Stage III Unresectable NSCLC 02:50 Lung Cancer Video Library - Das - The Role of Immunotherapy for Unresectable Stage 3 NSCLC Today 04:46 5-year survival outcomes from the PACIFIC trial 03:07 The Use of Durvalumab in Locally Advanced NSCLC 10:36 Patient Selection for Immunotherapy in LA NSCLC 25:26 Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents 01:27 Concurrent checkpoint inhibition with chemoradiotherapy in NSCLC 06:38 ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone 04:16 NSCLC Management Before and After the PACIFIC Trial 06:04 Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract cancer 03:34 HIMALAYA: Does underlying liver function impact efficacy of tremelimumab plus durvalumab for HCC? 30:01 Dr Mark Vincent | Management of NSCLC stage III Evidence and Experience so far More results